Codexis, a biocatalyst research company based in Redwood City, Ca., has signed a significant licensing deal with Merck & Co.
See the statement here. The terms weren’t disclosed, but the company tells VentureWire it is in the multimillions of dollars (sub required).
5:07 pm
VentureBeat » Biofuel action: Range Fuels breaks ground, Innovation Fuels gets investment, Codexis extends Shell collaboration said:
[...] can also be used for pharmaceuticals and other applications. In April, for instance, the company signed a large deal with Merck, a drug [...]
5:07 pm
VentureBeat » Biofuel action: Range Fuels breaks ground, Innovation Fuels gets investment, Codexis extends Shell collaboration said:
[...] can also be used for pharmaceuticals and other applications. In April, for instance, the company signed a large deal with Merck, a drug [...]